M&T Bank Corp decreased its position in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 13.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 516,882 shares of the company’s stock after selling 81,431 shares during the period. M&T Bank Corp’s holdings in Philip Morris International were worth $82,908,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in PM. Marquette Asset Management LLC increased its position in Philip Morris International by 1,677.8% during the 3rd quarter. Marquette Asset Management LLC now owns 160 shares of the company’s stock worth $26,000 after buying an additional 151 shares during the period. Dogwood Wealth Management LLC increased its position in Philip Morris International by 96.5% during the 3rd quarter. Dogwood Wealth Management LLC now owns 167 shares of the company’s stock worth $27,000 after buying an additional 82 shares during the period. Richards Merrill & Peterson Inc. bought a new position in Philip Morris International during the 4th quarter worth $28,000. Measured Wealth Private Client Group LLC bought a new position in Philip Morris International during the 3rd quarter worth $32,000. Finally, FNY Investment Advisers LLC bought a new position in Philip Morris International during the 3rd quarter worth $33,000. Institutional investors own 78.63% of the company’s stock.
Philip Morris International News Roundup
Here are the key news stories impacting Philip Morris International this week:
- Positive Sentiment: Goldman Sachs turned bullish ahead of the Q1 release, which supports upside expectations into the report and may limit downside if results beat. Goldman Sachs is bullish on Philip Morris ahead of earnings
- Positive Sentiment: The FDA renewed modified-risk authorization for IQOS, preserving an important regulatory and commercial advantage as PMI shifts revenue toward heat-not-burn products. This reduces regulatory execution risk for IQOS rollout. Philip Morris’ IQOS Retains FDA Modified-Risk Authorization
- Positive Sentiment: Analysts at Jefferies included PMI on a list of dividend stocks to hold in volatile markets, highlighting the stock’s income profile and defensive qualities for cautious investors. Philip Morris and 15 More Dividend Stocks to Play This Volatile Market
- Neutral Sentiment: Marketing/brand activity: PMI’s IQOS collaboration with Devialet at Milan Design Week boosts brand and product visibility but likely has limited near-term revenue impact. IQOS and Devialet Introduce “Soundsorial Design” Collaboration
- Neutral Sentiment: Broader market context: early S&P 500 earnings have been solid, which is supportive for risk appetite generally but doesn’t change PMI-specific drivers. S&P 500 Companies’ Earnings Season Off to Solid Start, Oppenheimer Says
- Negative Sentiment: Multiple earnings previews note that PMI reports Q1 results this week, which typically raises short-term volatility as investors trim positions to avoid earnings risk — a likely driver of today’s pullback. Philip Morris Q1 earnings on deck: What to expect
- Negative Sentiment: Pre-earnings coverage (“Everything You Need To Know Ahead Of Earnings”) reiterates uncertainty around revenue mix, IQOS momentum and currency/price/mix dynamics — factors that could produce a miss or conservative guidance and further pressure the stock. Philip Morris (PM) Reports Q1: Everything You Need To Know Ahead Of Earnings
Analyst Ratings Changes
Get Our Latest Stock Analysis on PM
Philip Morris International Stock Performance
Shares of NYSE PM opened at $153.33 on Wednesday. Philip Morris International Inc. has a 52 week low of $142.11 and a 52 week high of $191.30. The stock has a market capitalization of $238.97 billion, a P/E ratio of 21.09, a PEG ratio of 1.92 and a beta of 0.43. The stock’s fifty day moving average is $170.57 and its 200 day moving average is $163.81.
Philip Morris International (NYSE:PM – Get Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.83 by $0.13. Philip Morris International had a negative return on equity of 130.95% and a net margin of 12.09%.The company had revenue of $10.15 billion for the quarter, compared to analysts’ expectations of $9.95 billion. Equities research analysts forecast that Philip Morris International Inc. will post 8.36 earnings per share for the current year.
Philip Morris International Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 13th. Investors of record on Thursday, March 19th were paid a $1.47 dividend. The ex-dividend date of this dividend was Thursday, March 19th. This represents a $5.88 annualized dividend and a yield of 3.8%. Philip Morris International’s dividend payout ratio (DPR) is 80.88%.
Insider Activity
In related news, CFO Emmanuel Babeau sold 33,800 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $181.61, for a total value of $6,138,418.00. Following the sale, the chief financial officer directly owned 164,463 shares of the company’s stock, valued at $29,868,125.43. This trade represents a 17.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Jacek Olczak sold 80,000 shares of the firm’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $182.18, for a total value of $14,574,400.00. Following the completion of the sale, the chief executive officer directly owned 632,344 shares in the company, valued at $115,200,429.92. This trade represents a 11.23% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.13% of the company’s stock.
Philip Morris International Company Profile
Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.
PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.
Read More
Receive News & Ratings for Philip Morris International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Philip Morris International and related companies with MarketBeat.com's FREE daily email newsletter.
